Effects of adding different concentrations of melatonin (10
?7, 10
?9 and 10
?11 M) to maturation (Experiment 1; Control, IVM + 10
?7, IVM + 10
?9, IVM + 10
?11) and culture media (Experiment 2; Control, IVC + 10
?7, IVC + 10
?9, IVC + 10
?11) were evaluated on in vitro bovine embryonic
development. The optimal concentration of melatonin (10
?9 M) from Experiments 1–2 was tested in both maturation and/or culture media of Experiment 3 (Control, IVM + 10
?9, IVC + 10
?9, IVM /IVC + 10
?9). In Experiment 1, maturated oocytes from Control and IVM + 10
?9 treatments showed increased glutathione content, mitochondrial membrane potential and percentage of Gra
de I blastocysts (40.6% and 43%, respectively). In Experiment 2, an increase in the percentage of Gra
de I blastocysts was
detected in IVC + 10
?7 (43.5%; 56.7%) and IVC + 10
?9 (47.4%; 57.4%). Moreover, a lower number and percentage of apoptotic cells in blastocysts were observed in the IVC + 10
?9 group compared to Control (3.8 ± 0.6; 3.6%
versus 6.1 ± 0.6; 5.3%). In Experiment 3, the IVC + 10
?9 treatment increased percentage of Gra
de I blastocysts with a lower number of apoptotic cells compared to IVM /IVC + 10
?9 group (52.6%; 3.0 ± 0.5
versus 46.0%; 5.4 ± 1.0). The IVC + 10
?9 treatment also had a higher mRNA expression of antioxidant gene (SOD 2) compared to the Control, as well as the heat shock protein (HSPB 1) compared to the IVM + 10
?9. Reactive oxygen species production was greater in the IVM /IVC + 10
?9 treatment group. In conclusion, the 10
?9 M concentration of melatonin and the in vitro production phase in which it is used directly affected embryonic
development and quality.
相似文献